HARVARD BIOSCIENCE INC — Director's Dealing 2012

Jun 4, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2012-06-04

Reporting Person: UVEGES GEORGE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-06-01	Common Stock	A	8403	—	Acquired	18403	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-01	Stock option (right to buy)	$3.57	A	16100	Acquired	2022-06-01	Common Stock, par value $0.01 per share (16100)	Direct

Footnotes

F1: Includes (a) a deferred stock award of 8,403 restricted stock units which vest in equal installments on June 1, 2013; June 1, 2014 and June 1, 2015; and (b) 10,000 shares of common stock held by Mr. Uveges.

F2: The options vest in three equal installments on June 1, 2013, 2014 and 2015.